aluates Reports

$ 0.0

Automative

Global Oncology Based In-vivo CRO Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-10H1965

Global Oncology Based In vivo CRO Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Oncology Based In-vivo CRO Market Research Report 2025

Code: QYRE-Auto-10H1965

Report

September 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Crown Bioscience

Charles River Laboratory

ICON

Eurofins Scientific

Taconic Biosciences

Covance

Evotec AG

The Jackson Laboratory

WuXi AppTec

MI Bioresearch, Inc.

Champion Oncology, Inc.

Xentech

Oncology Based In-vivo CRO Market

The global market for Oncology Based In-vivo CRO was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible. This report focus on Oncology Based In-vivo CRO.

North American market for Oncology Based In-vivo CRO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Oncology Based In-vivo CRO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Oncology Based In-vivo CRO in Pharmaceutical & Biopharmaceutical Industries is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Oncology Based In-vivo CRO include Crown Bioscience, Charles River Laboratory, ICON Plc., Eurofins Scientific, Taconic Biosciences, Covance, EVOTEC, The Jackson Laboratory, Wuxi AppTec., MI Bioresearch, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Oncology Based In-vivo CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Based In-vivo CRO.

The Oncology Based In-vivo CRO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology Based In-vivo CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oncology Based In-vivo CRO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oncology Based In-vivo CRO Market Report

Report Metric	Details
Report Name	Oncology Based In-vivo CRO Market
Segment by Type	Blood Cancer Solid Tumors Other
Segment by Application	Pharmaceutical & Biopharmaceutical Industries Medical Device Companies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Crown Bioscience, Charles River Laboratory, ICON Plc., Eurofins Scientific, Taconic Biosciences, Covance, EVOTEC, The Jackson Laboratory, Wuxi AppTec., MI Bioresearch, Inc., Champion Oncology, Inc., Xentech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Based In-vivo CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oncology Based In-vivo CRO Market report?

Ans: The main players in the Oncology Based In-vivo CRO Market are Crown Bioscience, Charles River Laboratory, ICON Plc., Eurofins Scientific, Taconic Biosciences, Covance, EVOTEC, The Jackson Laboratory, Wuxi AppTec., MI Bioresearch, Inc., Champion Oncology, Inc., Xentech

What are the Application segmentation covered in the Oncology Based In-vivo CRO Market report?

Ans: The Applications covered in the Oncology Based In-vivo CRO Market report are Pharmaceutical & Biopharmaceutical Industries, Medical Device Companies, Others

What are the Type segmentation covered in the Oncology Based In-vivo CRO Market report?

Ans: The Types covered in the Oncology Based In-vivo CRO Market report are Blood Cancer, Solid Tumors, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oncology Based In-vivo CRO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Blood Cancer

1.2.3 Solid Tumors

1.2.4 Other

1.3 Market by Application

1.3.1 Global Oncology Based In-vivo CRO Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical & Biopharmaceutical Industries

1.3.3 Medical Device Companies

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oncology Based In-vivo CRO Market Perspective (2020-2031)

2.2 Global Oncology Based In-vivo CRO Growth Trends by Region

2.2.1 Global Oncology Based In-vivo CRO Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oncology Based In-vivo CRO Historic Market Size by Region (2020-2025)

2.2.3 Oncology Based In-vivo CRO Forecasted Market Size by Region (2026-2031)

2.3 Oncology Based In-vivo CRO Market Dynamics

2.3.1 Oncology Based In-vivo CRO Industry Trends

2.3.2 Oncology Based In-vivo CRO Market Drivers

2.3.3 Oncology Based In-vivo CRO Market Challenges

2.3.4 Oncology Based In-vivo CRO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oncology Based In-vivo CRO Players by Revenue

3.1.1 Global Top Oncology Based In-vivo CRO Players by Revenue (2020-2025)

3.1.2 Global Oncology Based In-vivo CRO Revenue Market Share by Players (2020-2025)

3.2 Global Oncology Based In-vivo CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oncology Based In-vivo CRO Revenue

3.4 Global Oncology Based In-vivo CRO Market Concentration Ratio

3.4.1 Global Oncology Based In-vivo CRO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oncology Based In-vivo CRO Revenue in 2024

3.5 Global Key Players of Oncology Based In-vivo CRO Head office and Area Served

3.6 Global Key Players of Oncology Based In-vivo CRO, Product and Application

3.7 Global Key Players of Oncology Based In-vivo CRO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Based In-vivo CRO Breakdown Data by Type

4.1 Global Oncology Based In-vivo CRO Historic Market Size by Type (2020-2025)

4.2 Global Oncology Based In-vivo CRO Forecasted Market Size by Type (2026-2031)

5 Oncology Based In-vivo CRO Breakdown Data by Application

5.1 Global Oncology Based In-vivo CRO Historic Market Size by Application (2020-2025)

5.2 Global Oncology Based In-vivo CRO Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oncology Based In-vivo CRO Market Size (2020-2031)

6.2 North America Oncology Based In-vivo CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oncology Based In-vivo CRO Market Size by Country (2020-2025)

6.4 North America Oncology Based In-vivo CRO Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oncology Based In-vivo CRO Market Size (2020-2031)

7.2 Europe Oncology Based In-vivo CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oncology Based In-vivo CRO Market Size by Country (2020-2025)

7.4 Europe Oncology Based In-vivo CRO Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oncology Based In-vivo CRO Market Size (2020-2031)

8.2 Asia-Pacific Oncology Based In-vivo CRO Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oncology Based In-vivo CRO Market Size by Region (2020-2025)

8.4 Asia-Pacific Oncology Based In-vivo CRO Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oncology Based In-vivo CRO Market Size (2020-2031)

9.2 Latin America Oncology Based In-vivo CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oncology Based In-vivo CRO Market Size by Country (2020-2025)

9.4 Latin America Oncology Based In-vivo CRO Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oncology Based In-vivo CRO Market Size (2020-2031)

10.2 Middle East & Africa Oncology Based In-vivo CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oncology Based In-vivo CRO Market Size by Country (2020-2025)

10.4 Middle East & Africa Oncology Based In-vivo CRO Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Crown Bioscience

11.1.1 Crown Bioscience Company Details

11.1.2 Crown Bioscience Business Overview

11.1.3 Crown Bioscience Oncology Based In-vivo CRO Introduction

11.1.4 Crown Bioscience Revenue in Oncology Based In-vivo CRO Business (2020-2025)

11.1.5 Crown Bioscience Recent Development

11.2 Charles River Laboratory

11.2.1 Charles River Laboratory Company Details

11.2.2 Charles River Laboratory Business Overview

11.2.3 Charles River Laboratory Oncology Based In-vivo CRO Introduction

11.2.4 Charles River Laboratory Revenue in Oncology Based In-vivo CRO Business (2020-2025)

11.2.5 Charles River Laboratory Recent Development

11.3 ICON Plc.

11.3.1 ICON Plc. Company Details

11.3.2 ICON Plc. Business Overview

11.3.3 ICON Plc. Oncology Based In-vivo CRO Introduction

11.3.4 ICON Plc. Revenue in Oncology Based In-vivo CRO Business (2020-2025)

11.3.5 ICON Plc. Recent Development

11.4 Eurofins Scientific

11.4.1 Eurofins Scientific Company Details

11.4.2 Eurofins Scientific Business Overview

11.4.3 Eurofins Scientific Oncology Based In-vivo CRO Introduction

11.4.4 Eurofins Scientific Revenue in Oncology Based In-vivo CRO Business (2020-2025)

11.4.5 Eurofins Scientific Recent Development

11.5 Taconic Biosciences

11.5.1 Taconic Biosciences Company Details

11.5.2 Taconic Biosciences Business Overview

11.5.3 Taconic Biosciences Oncology Based In-vivo CRO Introduction

11.5.4 Taconic Biosciences Revenue in Oncology Based In-vivo CRO Business (2020-2025)

11.5.5 Taconic Biosciences Recent Development

11.6 Covance

11.6.1 Covance Company Details

11.6.2 Covance Business Overview

11.6.3 Covance Oncology Based In-vivo CRO Introduction

11.6.4 Covance Revenue in Oncology Based In-vivo CRO Business (2020-2025)

11.6.5 Covance Recent Development

11.7 EVOTEC

11.7.1 EVOTEC Company Details

11.7.2 EVOTEC Business Overview

11.7.3 EVOTEC Oncology Based In-vivo CRO Introduction

11.7.4 EVOTEC Revenue in Oncology Based In-vivo CRO Business (2020-2025)

11.7.5 EVOTEC Recent Development

11.8 The Jackson Laboratory

11.8.1 The Jackson Laboratory Company Details

11.8.2 The Jackson Laboratory Business Overview

11.8.3 The Jackson Laboratory Oncology Based In-vivo CRO Introduction

11.8.4 The Jackson Laboratory Revenue in Oncology Based In-vivo CRO Business (2020-2025)

11.8.5 The Jackson Laboratory Recent Development

11.9 Wuxi AppTec.

11.9.1 Wuxi AppTec. Company Details

11.9.2 Wuxi AppTec. Business Overview

11.9.3 Wuxi AppTec. Oncology Based In-vivo CRO Introduction

11.9.4 Wuxi AppTec. Revenue in Oncology Based In-vivo CRO Business (2020-2025)

11.9.5 Wuxi AppTec. Recent Development

11.10 MI Bioresearch, Inc.

11.10.1 MI Bioresearch, Inc. Company Details

11.10.2 MI Bioresearch, Inc. Business Overview

11.10.3 MI Bioresearch, Inc. Oncology Based In-vivo CRO Introduction

11.10.4 MI Bioresearch, Inc. Revenue in Oncology Based In-vivo CRO Business (2020-2025)

11.10.5 MI Bioresearch, Inc. Recent Development

11.11 Champion Oncology, Inc.

11.11.1 Champion Oncology, Inc. Company Details

11.11.2 Champion Oncology, Inc. Business Overview

11.11.3 Champion Oncology, Inc. Oncology Based In-vivo CRO Introduction

11.11.4 Champion Oncology, Inc. Revenue in Oncology Based In-vivo CRO Business (2020-2025)

11.11.5 Champion Oncology, Inc. Recent Development

11.12 Xentech

11.12.1 Xentech Company Details

11.12.2 Xentech Business Overview

11.12.3 Xentech Oncology Based In-vivo CRO Introduction

11.12.4 Xentech Revenue in Oncology Based In-vivo CRO Business (2020-2025)

11.12.5 Xentech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Crown Bioscience

Charles River Laboratory

ICON

Eurofins Scientific

Taconic Biosciences

Covance

Evotec AG

The Jackson Laboratory

WuXi AppTec

MI Bioresearch, Inc.

Champion Oncology, Inc.

Xentech

List of Tables

Table 1. Global Oncology Based In-vivo CRO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Blood Cancer

Table 3. Key Players of Solid Tumors

Table 4. Key Players of Other

Table 5. Global Oncology Based In-vivo CRO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Oncology Based In-vivo CRO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Oncology Based In-vivo CRO Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Oncology Based In-vivo CRO Market Share by Region (2020-2025)

Table 9. Global Oncology Based In-vivo CRO Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Oncology Based In-vivo CRO Market Share by Region (2026-2031)

Table 11. Oncology Based In-vivo CRO Market Trends

Table 12. Oncology Based In-vivo CRO Market Drivers

Table 13. Oncology Based In-vivo CRO Market Challenges

Table 14. Oncology Based In-vivo CRO Market Restraints

Table 15. Global Oncology Based In-vivo CRO Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Oncology Based In-vivo CRO Market Share by Players (2020-2025)

Table 17. Global Top Oncology Based In-vivo CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based In-vivo CRO as of 2024)

Table 18. Ranking of Global Top Oncology Based In-vivo CRO Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Oncology Based In-vivo CRO Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Oncology Based In-vivo CRO, Headquarters and Area Served

Table 21. Global Key Players of Oncology Based In-vivo CRO, Product and Application

Table 22. Global Key Players of Oncology Based In-vivo CRO, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Oncology Based In-vivo CRO Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Oncology Based In-vivo CRO Revenue Market Share by Type (2020-2025)

Table 26. Global Oncology Based In-vivo CRO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Oncology Based In-vivo CRO Revenue Market Share by Type (2026-2031)

Table 28. Global Oncology Based In-vivo CRO Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Oncology Based In-vivo CRO Revenue Market Share by Application (2020-2025)

Table 30. Global Oncology Based In-vivo CRO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Oncology Based In-vivo CRO Revenue Market Share by Application (2026-2031)

Table 32. North America Oncology Based In-vivo CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Oncology Based In-vivo CRO Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Oncology Based In-vivo CRO Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Oncology Based In-vivo CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Oncology Based In-vivo CRO Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Oncology Based In-vivo CRO Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Oncology Based In-vivo CRO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Oncology Based In-vivo CRO Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Oncology Based In-vivo CRO Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Oncology Based In-vivo CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Oncology Based In-vivo CRO Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Oncology Based In-vivo CRO Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Oncology Based In-vivo CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Oncology Based In-vivo CRO Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Oncology Based In-vivo CRO Market Size by Country (2026-2031) & (US$ Million)

Table 47. Crown Bioscience Company Details

Table 48. Crown Bioscience Business Overview

Table 49. Crown Bioscience Oncology Based In-vivo CRO Product

Table 50. Crown Bioscience Revenue in Oncology Based In-vivo CRO Business (2020-2025) & (US$ Million)

Table 51. Crown Bioscience Recent Development

Table 52. Charles River Laboratory Company Details

Table 53. Charles River Laboratory Business Overview

Table 54. Charles River Laboratory Oncology Based In-vivo CRO Product

Table 55. Charles River Laboratory Revenue in Oncology Based In-vivo CRO Business (2020-2025) & (US$ Million)

Table 56. Charles River Laboratory Recent Development

Table 57. ICON Plc. Company Details

Table 58. ICON Plc. Business Overview

Table 59. ICON Plc. Oncology Based In-vivo CRO Product

Table 60. ICON Plc. Revenue in Oncology Based In-vivo CRO Business (2020-2025) & (US$ Million)

Table 61. ICON Plc. Recent Development

Table 62. Eurofins Scientific Company Details

Table 63. Eurofins Scientific Business Overview

Table 64. Eurofins Scientific Oncology Based In-vivo CRO Product

Table 65. Eurofins Scientific Revenue in Oncology Based In-vivo CRO Business (2020-2025) & (US$ Million)

Table 66. Eurofins Scientific Recent Development

Table 67. Taconic Biosciences Company Details

Table 68. Taconic Biosciences Business Overview

Table 69. Taconic Biosciences Oncology Based In-vivo CRO Product

Table 70. Taconic Biosciences Revenue in Oncology Based In-vivo CRO Business (2020-2025) & (US$ Million)

Table 71. Taconic Biosciences Recent Development

Table 72. Covance Company Details

Table 73. Covance Business Overview

Table 74. Covance Oncology Based In-vivo CRO Product

Table 75. Covance Revenue in Oncology Based In-vivo CRO Business (2020-2025) & (US$ Million)

Table 76. Covance Recent Development

Table 77. EVOTEC Company Details

Table 78. EVOTEC Business Overview

Table 79. EVOTEC Oncology Based In-vivo CRO Product

Table 80. EVOTEC Revenue in Oncology Based In-vivo CRO Business (2020-2025) & (US$ Million)

Table 81. EVOTEC Recent Development

Table 82. The Jackson Laboratory Company Details

Table 83. The Jackson Laboratory Business Overview

Table 84. The Jackson Laboratory Oncology Based In-vivo CRO Product

Table 85. The Jackson Laboratory Revenue in Oncology Based In-vivo CRO Business (2020-2025) & (US$ Million)

Table 86. The Jackson Laboratory Recent Development

Table 87. Wuxi AppTec. Company Details

Table 88. Wuxi AppTec. Business Overview

Table 89. Wuxi AppTec. Oncology Based In-vivo CRO Product

Table 90. Wuxi AppTec. Revenue in Oncology Based In-vivo CRO Business (2020-2025) & (US$ Million)

Table 91. Wuxi AppTec. Recent Development

Table 92. MI Bioresearch, Inc. Company Details

Table 93. MI Bioresearch, Inc. Business Overview

Table 94. MI Bioresearch, Inc. Oncology Based In-vivo CRO Product

Table 95. MI Bioresearch, Inc. Revenue in Oncology Based In-vivo CRO Business (2020-2025) & (US$ Million)

Table 96. MI Bioresearch, Inc. Recent Development

Table 97. Champion Oncology, Inc. Company Details

Table 98. Champion Oncology, Inc. Business Overview

Table 99. Champion Oncology, Inc. Oncology Based In-vivo CRO Product

Table 100. Champion Oncology, Inc. Revenue in Oncology Based In-vivo CRO Business (2020-2025) & (US$ Million)

Table 101. Champion Oncology, Inc. Recent Development

Table 102. Xentech Company Details

Table 103. Xentech Business Overview

Table 104. Xentech Oncology Based In-vivo CRO Product

Table 105. Xentech Revenue in Oncology Based In-vivo CRO Business (2020-2025) & (US$ Million)

Table 106. Xentech Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Oncology Based In-vivo CRO Picture

Figure 2. Global Oncology Based In-vivo CRO Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oncology Based In-vivo CRO Market Share by Type: 2024 VS 2031

Figure 4. Blood Cancer Features

Figure 5. Solid Tumors Features

Figure 6. Other Features

Figure 7. Global Oncology Based In-vivo CRO Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Oncology Based In-vivo CRO Market Share by Application: 2024 VS 2031

Figure 9. Pharmaceutical & Biopharmaceutical Industries Case Studies

Figure 10. Medical Device Companies Case Studies

Figure 11. Others Case Studies

Figure 12. Oncology Based In-vivo CRO Report Years Considered

Figure 13. Global Oncology Based In-vivo CRO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Oncology Based In-vivo CRO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Oncology Based In-vivo CRO Market Share by Region: 2024 VS 2031

Figure 16. Global Oncology Based In-vivo CRO Market Share by Players in 2024

Figure 17. Global Top Oncology Based In-vivo CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based In-vivo CRO as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Oncology Based In-vivo CRO Revenue in 2024

Figure 19. North America Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Oncology Based In-vivo CRO Market Share by Country (2020-2031)

Figure 21. United States Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Oncology Based In-vivo CRO Market Share by Country (2020-2031)

Figure 25. Germany Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Oncology Based In-vivo CRO Market Share by Region (2020-2031)

Figure 33. China Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Oncology Based In-vivo CRO Market Share by Country (2020-2031)

Figure 41. Mexico Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Oncology Based In-vivo CRO Market Share by Country (2020-2031)

Figure 45. Turkey Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Oncology Based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Crown Bioscience Revenue Growth Rate in Oncology Based In-vivo CRO Business (2020-2025)

Figure 49. Charles River Laboratory Revenue Growth Rate in Oncology Based In-vivo CRO Business (2020-2025)

Figure 50. ICON Plc. Revenue Growth Rate in Oncology Based In-vivo CRO Business (2020-2025)

Figure 51. Eurofins Scientific Revenue Growth Rate in Oncology Based In-vivo CRO Business (2020-2025)

Figure 52. Taconic Biosciences Revenue Growth Rate in Oncology Based In-vivo CRO Business (2020-2025)

Figure 53. Covance Revenue Growth Rate in Oncology Based In-vivo CRO Business (2020-2025)

Figure 54. EVOTEC Revenue Growth Rate in Oncology Based In-vivo CRO Business (2020-2025)

Figure 55. The Jackson Laboratory Revenue Growth Rate in Oncology Based In-vivo CRO Business (2020-2025)

Figure 56. Wuxi AppTec. Revenue Growth Rate in Oncology Based In-vivo CRO Business (2020-2025)

Figure 57. MI Bioresearch, Inc. Revenue Growth Rate in Oncology Based In-vivo CRO Business (2020-2025)

Figure 58. Champion Oncology, Inc. Revenue Growth Rate in Oncology Based In-vivo CRO Business (2020-2025)

Figure 59. Xentech Revenue Growth Rate in Oncology Based In-vivo CRO Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Oncology Based Preclinical CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Preclinical Oncology CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Preclinical Contract Research Organization CRO Market Research Report 2025

Global Pharmaceutical Development Preclinical CRO Market Research Report 2025

Global Pre Clinical CROs Services Market Research Report 2024

Global Preclinical CRO Treatment Market Insights Forecast to 2030

Clinical CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Contract Research Organisations CROs Market Research Report 2024

Pre Clinical Contract Research Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Full Service CRO Market Research Report 2024

Global CRO in Clinical Trials Market Research Report 2024

Global Full Service Clinical Research Organization CRO Market Research Report 2025

Global Clinical Contract Research Organization Services Market Research Report 2024

Global Clinical and Non clinical Contract Research Organization Services Market Research Report 2024

Global Cell and Gene Therapy CRO Market Research Report 2024

Global CRO Services Market Research Report 2024

Global Healthcare Contract Research Organization Market Insights Forecast to 2030

Global Contract Research Organization Solution Market Research Report 2025

Global Clinical CRO Laboratory Services Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions